Yesterday CosmeticsDesign.com featured Sirona Biochem (SBM:tsxv) in an article highlighting the biotechnological advancements they’ve made in the development of a Skin Lightener which has already begun generating big interest from some of the world’s top cosmetic companies. The Skin Lightener market is forecasted to be worth 19.8 billion by 2018. If you would like to view information on Sirona’s Skin Lightener development, here’s a link: Sirona’s Skin Lightener Program
The following is the link towards the article published by CosmeticsDesign.com
Sirona Biochem claims to have made a big leap in the development of skin whitening ingredients
Canada-based biotech company Sirona Biochem believes it has made a big leap in the area of skin whitening ingredients, with its compound developed using fluorination technology.
About Sirona Biochem
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France. The Company specializes in the stabilization of carbohydrate molecules, with the goal of improving compounds’ efficacy and safety. Sirona Biochem’s compounds are patented as new chemical entities for maximum commercial protection and revenue potential. Newly developed compounds are licensed to leading companies around the world in return for licensing and milestone fees and ongoing royalty payments. TFChem, Sirona Biochem’s wholly-owned French laboratory, is a recipient of multiple French national scientific awards and a European Union and French government grant. For more information visit www.sironabiochem.com.